Adm1n at 11:06, 14 April 2015

2015-04-14T11:06:28Z

Adm1n: Created page with "'''O-1871''' is a potent cannabinoid agonist which was invented by Billy R Martin and Raj K Razdan in 2002. It has a CB1 receptor affinity of 2.0nM and a CB2 receptor..."

2015-04-14T11:06:16Z

Created page with "'''O-1871''' is a potent cannabinoid agonist which was invented by Billy R Martin and Raj K Razdan in 2002. It has a CB1 receptor affinity of 2.0nM and a CB2 receptor..."

New page

'''O-1871''' is a potent [[cannabinoid]] agonist which was invented by Billy R Martin and Raj K Razdan in 2002. It has a [[CB1 receptor]] affinity of 2.0nM and a CB2 receptor affinity of 0.3nM. Structurally, O-1871 is a cyclohexylphenol derivative related to [[CP 47,497]], and so is illegal in most jurisdictions where CP 47,497 and its derivatives are banned. However the 3,3-dimethylcyclohexyl substituent of O-1871 can be replaced by various other groups, producing other potent compounds such as the cycloheptyl derivative O-1656 and the 2-adamantyl derivative O-1660, as well as the corresponding 3,5-dichlorophenyl derivative, which are not cyclohexylphenol derivatives.

== See also ==

*[[CP 55,940]]

*[[Cannabidiol]]

*[[Cannabicyclohexanol]]

← Older revision		Revision as of 11:06, 14 April 2015
Line 1:		Line 1:
−	'''O-1871''' is a potent [[cannabinoid]] agonist which was invented by Billy R Martin and Raj K Razdan in 2002. It has a [[CB1 ~~receptor~~]] affinity of 2.0nM and a CB2 receptor affinity of 0.3nM. Structurally, O-1871 is a cyclohexylphenol derivative related to [[CP 47,497]], and so is illegal in most jurisdictions where CP 47,497 and its derivatives are banned. However the 3,3-dimethylcyclohexyl substituent of O-1871 can be replaced by various other groups, producing other potent compounds such as the cycloheptyl derivative O-1656 and the 2-adamantyl derivative O-1660, as well as the corresponding 3,5-dichlorophenyl derivative, which are not cyclohexylphenol derivatives.	+	'''O-1871''' is a potent [[cannabinoid]] agonist which was invented by Billy R Martin and Raj K Razdan in 2002. It has a [[CB1]] receptor affinity of 2.0nM and a CB2 receptor affinity of 0.3nM. Structurally, O-1871 is a cyclohexylphenol derivative related to [[CP 47,497]], and so is illegal in most jurisdictions where CP 47,497 and its derivatives are banned. However the 3,3-dimethylcyclohexyl substituent of O-1871 can be replaced by various other groups, producing other potent compounds such as the cycloheptyl derivative O-1656 and the 2-adamantyl derivative O-1660, as well as the corresponding 3,5-dichlorophenyl derivative, which are not cyclohexylphenol derivatives.

O-1871 - Revision history

Adm1n at 11:06, 14 April 2015

Adm1n: Created page with "'''O-1871''' is a potent cannabinoid agonist which was invented by Billy R Martin and Raj K Razdan in 2002. It has a CB1 receptor affinity of 2.0nM and a CB2 receptor..."